This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Metabolic Bone Disorder
Information about Metabolic Bone Disorder: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Metabolic Bone Disorder
Most recent studies have shown that Metabolic Bone Disorder shares some biological mechanisms with bone-diseases, diabetes-mellitus, fracture, hypercalcemia, hyperparathyroidism-secondary, kidney-diseases, kidney-failure-chronic, malignant-neoplasms, neoplasms, osteitis-deformans, osteomalacia, osteopenia, osteoporosis, osteoporosis-postmenopausal, pain, pathological-fracture, renal-osteodystrophy, vitamin-d-deficiency.
Among the many pathways, these few ones have gauged particular interests from scientists studying Metabolic Bone Disorder, and have been seen in publications frequently: Aging, Bone Development, Bone Mineralization, Bone Remodeling, Bone Resorption, Cell Proliferation, Dna Methylation, Excretion, Glomerular Filtration, Intestinal Absorption, Localization, Menopause, Methylation, Ossification, Osteoblast Differentiation, Osteoclast Differentiation, Pathogenesis, Regeneration, Secretion, Transport
Quite a number of genes have been found to play important roles in Metabolic Bone Disorder, such as ALPP, ASRGL1, ATRNL1, BEST1, BGLAP, CALCA, CCL27, DMD, IGF1, MECP2, PTH, PTRH1, SLPI, SS18L1, TNF, TNFRSF11A, TNFRSF11B, TNFSF11. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.